Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Novabay Pharmaceuticals (NBY)

Novabay Pharmaceuticals (NBY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,576
  • Shares Outstanding, K 52,618
  • Annual Sales, $ 8,420 K
  • Annual Income, $ -5,820 K
  • 60-Month Beta 3.30
  • Price/Sales 1.37
  • Price/Cash Flow N/A
  • Price/Book 0.66
Trade NBY with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.11
  • Most Recent Earnings 0.00 on 05/12/22
  • Next Earnings Date 08/11/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.04
  • Growth Rate Est. (year over year) +2,497,600.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1900 +10.53%
on 06/13/22
0.3500 -40.00%
on 06/02/22
+0.0175 (+9.09%)
since 05/27/22
3-Month
0.1711 +22.74%
on 05/12/22
0.3500 -40.00%
on 06/02/22
-0.1051 (-33.35%)
since 03/28/22
52-Week
0.1711 +22.74%
on 05/12/22
0.7700 -72.73%
on 09/28/21
-0.4700 (-69.12%)
since 06/28/21

Most Recent Stories

More News
NovaBay Pharmaceuticals Reports First Quarter 2022 Financial Results

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) reports financial results for the three months ended March 31, 2022 and provides a business update. Financial results for the first quarter of 2022...

NBY : 0.2100 (-4.55%)
NovaBay Pharmaceuticals Expands Top-Selling DERMAdoctor Kakadu C and Calm Cool + Corrected Collections with New Anti-Aging Formulations

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces the expansion...

NBY : 0.2100 (-4.55%)
NovaBay Pharmaceuticals to Hold First Quarter 2022 Conference Call on May 12

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three months ended March 31, 2022 after market close on Thursday, May 12, 2022 and will hold...

NBY : 0.2100 (-4.55%)
NovaBay Pharmaceuticals CEO Issues Letter to Stockholders

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces that Chief Executive Officer Justin Hall has issued the following Letter to Stockholders:

NBY : 0.2100 (-4.55%)
NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to QVC® to Discuss DERMAdoctor’s Eczema Treatment

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that Chief Product Officer...

NBY : 0.2100 (-4.55%)
NovaBay Pharmaceuticals Introduces Hydrating Cleansing Oil to its DERMAdoctor Calm Cool + Corrected Product Line

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces the launch...

NBY : 0.2100 (-4.55%)
NovaBay Pharmaceuticals Reports 2021 Fourth Quarter and Full Year Financial Results

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) reports financial results for the three and 12 months ended December 31, 2021 and provides a business update. Financial results include the operations...

NBY : 0.2100 (-4.55%)
NovaBay Pharmaceuticals to Hold 2021 Fourth Quarter and Full Year Conference Call on March 29

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2021 after market close on Tuesday, March 29, 2022...

NBY : 0.2100 (-4.55%)
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

GROM and BBAI are leading our lists

NBY : 0.2100 (-4.55%)
GROM : 0.4520 (+2.73%)
HUIZ : 1.2500 (+0.81%)
VIEW : 1.5700 (+3.97%)
STNE : 8.88 (+0.45%)
NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Present DERMAdoctor Eczema Treatment as QVC® On-Air Guest

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that Chief Product Officer...

NBY : 0.2100 (-4.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. NovaBay has discovered and is developing a class of antimicrobial compounds,...

See More

Key Turning Points

3rd Resistance Point 0.2618
2nd Resistance Point 0.2473
1st Resistance Point 0.2337
Last Price 0.2100
1st Support Level 0.2056
2nd Support Level 0.1911
3rd Support Level 0.1775

See More

52-Week High 0.7700
Fibonacci 61.8% 0.5412
Fibonacci 50% 0.4706
Fibonacci 38.2% 0.3999
Last Price 0.2100
52-Week Low 0.1711

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar